Expected US Company Earnings on Friday, November 14th, 2025

Lifeward Ltd. (LFWD) is expected to report $-0.14 for Q3 2025

Bit Digital Inc. (BTBT) is expected to report $0 for Q3 2025

Scholar Rock Holding Corporation (SRRK) is expected to report $-0.88 for Q3 2025

Legence Corp. (LGN) is expected to report $0.03 for Q3 2025

TOMI Environmental Solutions Inc. (TOMZ) is expected to report $-0.01 for Q3 2025

LanzaTech Global Inc. (LNZA) is expected to report $-12.42 for Q3 2025

Dragonfly Energy Holdings Corp (DFLI) is expected to report $-0.71 for Q3 2025

Ascot Resources Ltd. (AOTVF) is expected to report $0 for Q3 2025

Modiv Industrial Inc. Class C (MDV) is expected to report $0.34 for Q3 2025

Biotricity Inc. (BTCY) is expected to report $-0.08 for Q2 2026

Spire Inc. (SR) is expected to report $-0.46 for Q4 2025

Moleculin Biotech Inc. (MBRX) is expected to report $-0.2 for Q3 2025

Gauzy Ltd. (GAUZ) is expected to report $-0.24 for Q3 2025

Iterum Therapeutics plc (ITRM) is expected to report $-0.13 for Q3 2025

Twist Bioscience Corporation (TWST) is expected to report $-0.4 for Q4 2025

Sigma Lithium Corporation (SGML) is expected to report $-0.09 for Q3 2025

Alithya Group inc. (ALYAF) is expected to report $0.03 for Q2 2026

SBC Medical Group Holdings, Inc. (SBC) is expected to report $0.13 for Q3 2025

Entera Bio Ltd. (ENTX) is expected to report $-0.09 for Q3 2025

Neo Performance Materials Inc (NOPMF) is expected to report $0.14 for Q3 2025

Monopar Therapeutics Inc. (MNPR) is expected to report $-0.46 for Q3 2025

HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.01 for Q2 2026

Banzai International Inc. (BNZI) is expected to report $-1.33 for Q3 2025

Forge Global Holdings Inc. (FRGE) is expected to report $-1 for Q3 2025

Mersana Therapeutics Inc. (MRSN) is expected to report $-1.44 for Q3 2025

LM Funding America Inc. (LMFA) is expected to report $-0.49 for Q3 2025

Quantum Computing Inc. (QUBT) is expected to report $-0.05 for Q3 2025

Prairie Operating Co. (PROP) is expected to report $0.28 for Q3 2025

MiNK Therapeutics Inc. (INKT) is expected to report $-0.86 for Q3 2025

Forian Inc. (FORA) is expected to report $-0.04 for Q3 2025